会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明公开
    • GEL-FORMING AGENT CONTAINING SULFONAMIDE AND CHITOSAN AND HAVING A POWDERED DOSAGE FORM
    • GELBILDENDER STOFF MIT SULFONAMID UND壳聚糖和麻省理工学院EINER PULVRIGEN DARREICHUNGSFORM
    • EP3087990A4
    • 2017-07-19
    • EP14874363
    • 2014-12-22
    • GREENEVER
    • SONOO YOSHIKO
    • A61K31/722A61K9/14A61K31/635A61L26/00A61L31/04A61L31/16A61P17/02A61P43/00
    • A61L26/0066A61K31/635A61L26/0023A61L26/0028A61L31/042A61L31/16A61L2300/216A61L2300/406C08L5/08
    • The present invention relates to a gel-forming agent comprising a sulfa agent and a chitosan agent and having a powdered dosage form. In addition, the present invention provides a kit comprising the gel-forming agent of the present invention and a method comprising a step for applying the gel-forming agent of the present invention. According to the present invention, a gel-forming agent is provided that demonstrates a therapeutic effect that is more remarkable than that of conventional sulfa agents and chitosan agents alone, and more particularly, a gel-forming agent for protecting an exudative affected area and a gel-forming agent for treating a wound. Namely, by the applying the combination of a sulfa agent and a chitosan agent in the form of a powder, the pH of the affected area is maintained in a range that demonstrates a therapeutic effect, and antibacterial action of the sulfa agent is demonstrated. In addition, the moist environment at the affected area is suitably maintained for suitable granulation. In addition, as a result of being a powder, the use of a suitable dissipating container enables the gel-forming agent to be dispersed by a person performing treatment without making direct contact with the affected area.
    • 本发明涉及包含磺胺试剂和壳聚糖试剂并具有粉末剂型的凝胶形成剂。 此外,本发明提供了包含本发明的凝胶形成剂的试剂盒和包括施用本发明的凝胶形成剂的步骤的方法。 根据本发明,提供了一种凝胶形成剂,其显示出比常规磺胺制剂和壳聚糖制剂更显着的治疗效果,并且更具体地说,涉及一种用于保护渗出性患病区域的凝胶形成剂和 用于治疗伤口的凝胶形成剂。 即,通过将粉末状的磺胺试剂与壳聚糖试剂组合使用,可以将受影响部位的pH保持在显示治疗效果的范围内,并且可以发挥磺胺试剂的抗菌作用。 此外,受影响区域的潮湿环境适宜保持适当的造粒。 另外,作为粉末的结果,使用合适的散发容器使得凝胶形成剂能够由正在进行治疗的人分散而不直接接触患病区域。
    • 6. 发明公开
    • GEL-FORMING AGENT CONTAINING SULFONAMIDE AND CHITOSAN AND HAVING A POWDERED DOSAGE FORM
    • GELBILDENDER STOFF MIT SULFONAMID UND CHITOSAN UND MIT EINER PULVRIGEN DARREICHUNGSFORM
    • EP3087990A1
    • 2016-11-02
    • EP14874363.6
    • 2014-12-22
    • Greenever
    • SONOO, Yoshiko
    • A61K31/722A61K9/14A61K31/635A61P17/02A61P43/00
    • A61L26/0066A61K31/635A61L26/0023A61L26/0028A61L31/042A61L31/16A61L2300/216A61L2300/406C08L5/08
    • The present invention relates to a gel-forming agent comprising a sulfa agent and a chitosan agent and having a powdered dosage form. In addition, the present invention provides a kit comprising the gel-forming agent of the present invention and a method comprising a step for applying the gel-forming agent of the present invention. According to the present invention, a gel-forming agent is provided that demonstrates a therapeutic effect that is more remarkable than that of conventional sulfa agents and chitosan agents alone, and more particularly, a gel-forming agent for protecting an exudative affected area and a gel-forming agent for treating a wound. Namely, by the applying the combination of a sulfa agent and a chitosan agent in the form of a powder, the pH of the affected area is maintained in a range that demonstrates a therapeutic effect, and antibacterial action of the sulfa agent is demonstrated. In addition, the moist environment at the affected area is suitably maintained for suitable granulation. In addition, as a result of being a powder, the use of a suitable dissipating container enables the gel-forming agent to be dispersed by a person performing treatment without making direct contact with the affected area.
    • 本发明涉及包含磺胺剂和壳聚糖剂并具有粉末剂型的凝胶形成剂。 此外,本发明提供了包含本发明的凝胶形成剂的试剂盒和包含施加本发明的凝胶形成剂的步骤的方法。 根据本发明,提供一种凝胶形成剂,其表现出比单独的常规磺胺剂和壳聚糖剂更显着的治疗效果,更具体地,涉及用于保护渗出性影响区域的凝胶形成剂和 用于治疗伤口的凝胶形成剂。 也就是说,通过以粉末形式施用磺胺剂和壳聚糖剂的组合,将受影响区域的pH保持在显示治疗效果的范围内,并且证明了磺胺剂的抗菌作用。 此外,适当地保持受影响区域的潮湿环境以适合造粒。 此外,作为粉末的结果,使用合适的消散容器使得凝胶形成剂能够由进行处理的人分散,而不与受影响的区域直接接触。